On the morning of January 3,Kexing Biopharm signed an international commercialization cooperation agreement onEribulin Mesylate Injection, securing exclusive commercialization licensing and supply of the product from Xiling Lab Co., Ltd. in 36
SHENZHEN, China, Jan. 5, 2024 /PRNewswire/ On the morning of January 3, Kexing Biopharm signed an international commercialization cooperation agreement on
Stock Market | FinancialContent Business Page financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.
Qingdao, China (Newsfile Corp. - April 27, 2023) - The 88th API China, a prestigious pharmaceutical event, took place at the Qingdao Cosmopolitan Exposition Exhibition Centre, where regional representatives